Navigation Links
BIO-key(R) Announces Third Quarter 2008 Earnings Release and Conference Call Schedule
Date:11/7/2008

WALL, N.J., Nov. 7 /PRNewswire-FirstCall/ -- BIO-key International, Inc. (OTC Bulletin Board: BKYI) today announced plans to release third quarter 2008 financial results on Friday, November 14, 2008 before the market opens. In conjunction with the release, BIO-key has scheduled a conference call, which will be broadcast live over the Internet on Friday, November 14, 2008 at 10:00 a.m. Eastern Time.

What: BIO-key International, Inc. Third Quarter 2008 Earnings Conference

Call

When: Friday, November 14, 2008 - 10:00 a.m. Eastern Time

Where: Live via phone by dialing 303-262-2053 and asking for the BIO-key

call at least 10 minutes prior to the start time. Or live over

the Internet by logging on to the web address below.

Where: http://www.bio-key.com

A telephonic replay of the conference call will be available through 11:59 p.m. Eastern Time on November 21, 2008 and may be accessed by calling 303-590-3000 and using the passcode 11122159#. Also, an archive of the webcast will be available shortly after the call on http://www.bio-key.com for a period of three months.

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions and information services to law enforcement departments, public safety agencies, and government and private sector customers. BIO-key's mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases. BIO-key's high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise data to improve security, convenience and privacy and to reduce identity theft. Over 750 police departments in North America use BIO-key solutions, making BIO-key the leading supplier of mobile and wireless solutions for law enforcement. (http://www.bio-key.com)

Contacts: BIO-key International, Inc.

Bud Yanak

732-359-1113

DRG&E

Gus Okwu, Managing Director

404-532-0086


'/>"/>
SOURCE BIO-key International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BIO-key(R) Biometric Identification Solution Deployed by McKesson
2. BIO-key(R) Awarded Contract to Deploy Incident Reporting System for Littleton, CO Police Department
3. BioMS Medical Announces Third Quarter 2008 Results
4. Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
5. deCODE genetics Announces Third Quarter 2008 Financial Results
6. Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
7. Morria Biopharmaceuticals Plc Announces Positive Clinical Results for MRX-4 in its Phase II Clinical Study in Allergic Rhinitis Patients
8. SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
9. Advanced Life Sciences Announces Third Quarter 2008 Financial Results
10. Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2008 Results and Announces Share Repurchase
11. SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology:
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):